PepGen prices $125M stock offering at $5 per share
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PepGen Inc. (PEPG) priced a public offering of 25,000,000 common shares at $5.00 per share, for expected gross proceeds of $125 million before underwriting discounts, commissions and expenses. The company granted the underwriters a 30-day option to purchase up to 3,750,000 additional shares at the public offering price, less discounts and commissions. Estimated net proceeds are approximately $116.9 million, or approximately $134.5 million if the option is exercised in full.
PepGen intends to use the net proceeds for ongoing clinical development of its product candidate, working capital and other general corporate purposes. The offering is expected to close on or about November 13, 2026, subject to customary closing conditions. The shares are being offered under an effective Form S-3 shelf registration statement and related prospectus supplement. Leerink Partners, Stifel and Guggenheim Securities are joint bookrunning managers; Oppenheimer & Co. is passive bookrunner and H.C. Wainwright & Co. is lead manager.
Filing Explained
PepGen agreed to issue 25 million new common shares, which would increase the share count and reduce existing holders’ percentage ownership if completed, absent offsetting changes; the offering remains subject to customary closing conditions and is expected to close around
8-K Event Classification
Key Figures
Key Terms
gross proceeds financial
underwriting discounts and commissions financial
shelf registration statement regulatory
prospectus supplement regulatory
joint bookrunning managers financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which firms are managing PEPG’s public offering?
AI-generated analysis. How Rhea-AI works. Not financial advice.